Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)Recruiting
NCT07318558Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Ovarian Neoplasms · Ovarian Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Active Not Recruiting
NCT05269394Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +11 more
An Open-label Study of AZD0120 in Adults With Multiple SclerosisRecruiting
NCT07224373Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Multiple Sclerosis
United States, Australia, Canada, Germany, United Kingdom
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)Recruiting
NCT06843447Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Ovarian Cancer Recurrent
United States, Canada, Israel, Spain, United Kingdom
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsRecruiting
NCT06772623Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: AbbVie
Non Small Cell Lung Carcinoma
United States, Belgium, China, France, Germany +9 more
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)Recruiting
NCT07489495Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Argentina, Australia, Brazil, Czechia +12 more
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseRecruiting
NCT07064473Phase 3Updated Jul 27, 2026
Sponsor: Boehringer Ingelheim
Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular Diseases
United States, Argentina, Australia, Austria, Belgium +46 more
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Recruiting
NCT06841354Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +29 more
Drug-induced Liver Injury: Itching StudyRecruiting
NCT06446609N/AUpdated Jul 27, 2026
Sponsor: University of Nottingham
Drug Induced Liver Injury · Pruritus
United Kingdom
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive Not Recruiting
NCT05668013Phase 2Updated Jul 27, 2026
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Crohn Disease · Colitis, Ulcerative
United States, Austria, Bulgaria, Czechia, Georgia +11 more
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the AortaRecruiting
NCT07078383NAUpdated Jul 27, 2026
Sponsor: Vascutek Ltd.
Aortic Aneurysm · Aortic Aneurysm and Dissection · Aortic Diseases · Aneurysm of Aorta, Thoracic
United States, Austria, Germany, Netherlands, United Kingdom
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's DiseaseActive Not Recruiting
NCT06384573Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimer's Disease · Dementia · Alzheimer's Disease, Familial
United States, Australia, United Kingdom
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint InRecruiting
NCT06745908Phase 3Updated Jul 27, 2026
Sponsor: ImmunityBio, Inc.
NSCLC Stage IV
United States, Canada, United Kingdom
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLRecruiting
NCT07007312Phase 3Updated Jul 27, 2026
Sponsor: Kura Oncology, Inc.
Acute Myeloid Leukemia (AML)
United States, Australia, Belgium, Canada, Czechia +11 more
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Recruiting
NCT06393374Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple-Negative Breast Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)Recruiting
NCT07216703Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Cervical Cancer
United States, Argentina, Austria, Belgium, Brazil +22 more
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)Recruiting
NCT07419295Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Argentina, Australia, Belgium, Brazil +11 more
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple MyelomaRecruiting
NCT06158841Phase 3Updated Jul 27, 2026
Sponsor: AbbVie
Multiple Myeloma
United States, Australia, Austria, Belgium, Canada +20 more
Impact Of A Phe-Restricted Diet On Gut Health In Children With PKURecruiting
NCT07728032N/AUpdated Jul 27, 2026
Sponsor: Birmingham Women's and Children's NHS Foundation Trust
Phenylketonuria
United Kingdom
Study of GS-4528 in Adults With Solid TumorsActive Not Recruiting
NCT05840224Phase 1Updated Jul 27, 2026
Sponsor: Gilead Sciences
Solid Tumor
United States, Canada, South Korea, Spain, Taiwan +1 more
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)Recruiting
NCT07157254Phase 2Updated Jul 27, 2026
Sponsor: Ultragenyx Pharmaceutical Inc
Angelman Syndrome
United States, Argentina, Brazil, France, Israel +3 more
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic ArthritisRecruiting
NCT04804553Phase 3Updated Jul 24, 2026
Sponsor: Amgen
Active Juvenile Psoriatic Arthritis
Austria, Belgium, France, Germany, Greece +10 more
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)Active Not Recruiting
NCT06436742Phase 1Updated Jul 24, 2026
Sponsor: argenx
Congenital Myasthenic Syndrome · CMS
United States, Canada, France, Italy, Spain +1 more
Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended PeriodCompleted
NCT07400614NAUpdated Jul 24, 2026
Sponsor: PepsiCo Global R&D
Alertness
United Kingdom
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)Recruiting
NCT07366034Phase 3Updated Jul 24, 2026
Sponsor: Boehringer Ingelheim
Fibrosing Interstitial Lung Disease
United States, Argentina, Australia, Belgium, Brazil +17 more

Previous page Next page